baber/WOPTO huggingface dataset:
Patent AU-1457797-A (AU)
Title: Methods for the preparation of resins with ligands attached thereto through a linking group comprising sulfide, sulfoxide, sulfone or sulfonate functionality
Inventor: BURTON SIMON C
IPC: B01J20/289
Filed: 1997-01-10
Abstract: Methods for the preparation of chromatographic resins comprising a support matrix, having ligands capable of binding a target compound covalently attached thereto through a linking group comprising sulfide, sulfoxide, sulfone or sulfonate functionality. Specifically, in the disclosed methods, a support matrix comprising ethylenically unsaturated functionality is contacted with a thiol group or a bisulfite salt under free radical reaction conditions. In the case of the reaction with the thiol group, subsequent optional oxidation of the sulfide to the sulfone or sulfoxide functionality may occur. <IMAGE>
Patent AU-1474301-A (AU)
Title: Apparatus and method for digital filing
Inventor: IRONS STEVEN W
IPC: G06V30/10
Filed: 2000-11-08
Abstract: According to the preferred embodiments of the present invention, an apparatus and method for a digital filing system is disclosed. In this context, digital filing refers to the efficient management of paper-based information from its receipt at the desktop through an indexing, scanning, image storage, and image retrieval process. The preferred embodiments of the present invention provide for easy and effective indexing, imaging, storing, retrieving and managing of paper-based documents, transforming them into electronic documents using a system which incorporates many existing office resources. The proposed system and method implements a desktop solution for digital filing, which can be made available to each worker. Uniquely, the digital filing system of the present invention also allows users to index and label documents prior to scanning/imaging by using either a dedicated desktop labeling mechanism or pre-printed labels. The most preferred embodiments of the present invention utilize individual pre-printed labels that are dispensed one at a time from a "pop-up" dispensing mechanism. Each of the pre-printed labels contains a globally unique document identifier which is affixed to the lead page of a paper-based document. The globally unique file name or identifier is synchronized with a computerized database so that the digital image of the paper-based document and index information associated with the digital image can be stored and retrieved when the document is subsequently scanned.
Patent AU-1545888-A (AU)
Title: Hardenable composition based on branched acrylates with carboxyl groups and/or branched acrylates with epoxy groups and aminoplastic resins
Inventor: JUNG WERNER ALFONS
IPC: C08G59/50
Filed: 1988-03-25
Abstract: A hardenable composition comprises: A) a polymer with at least 2 COOH groups, B) a polymer with at least 2 epoxy groups, C) an aminoplastic resin. At least one of the components A) or B) is based on a branched soluble acrylate copolymer for the manufacture of which more than 3 to 30 wt.%, with respect to the total weight of the monomers, of a monomer with at least two polymerizable olefinically unsaturated double bonds is used and the ratios of the quantities of the individual components are chosen so that the molar ratio of the carbonyl groups of component A) to the epoxy groups of component B) is between 3:1 and 1:3 and that the ratio of the weight of the epoxy resin components to the weight of the aminoplastic resin components is between 65:35 wt.% and 98:2 wt.%. The invention also relates to coating materials based on the hardenable composition.
Patent AU-1650301-A (AU)
Title: Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same
Inventor: SHINOZAKI KATSUO
IPC: A61P1/04
Filed: 2000-12-01
Abstract: Provided are calcium salts of a 1,5-benzodiazepine derivative represented by the following formula (I): <CHEM> (wherein, R<1> represents a lower alkyl group, R<2> represents a phenyl or cyclohexyl group, and Y represents a single bond or a lower alkylene group); a process for preparing the salts; and drugs containing the same as the active ingredient. The compounds exhibit a potent inhibitory activity against the secretion of gastric acid and potent antagonism against gastrin and/or CCK-B receptor.
Patent AU-1753195-A (AU)
Title: Stray arc protective device, especially for low-voltage switching installations for distributing electric power
Inventor: WEY PAUL
IPC: H01H79/00
Filed: 1995-02-06
Abstract: A stray arc protective device consisting of an energy store, a coil, at least one stray arc detector controlling a switching component fitted between the coil and the energy store and a triggering cartridge with a vacuum which generates a metallic short circuit under the effect of the induction current generated by the coil, is to be improved in such a way that the components and especially the energy store can be made more compact and the triggering cartridge is easy to produce. This is achieved in that the triggering cartridge (1) consists of a first cup-like part (1a) with a tubular section (4) and a second part (1b), an insulating tube (21) or ring is fitted between the open end of the tubular section (4) or the first part (1a) of the cartridge and its second part (1b), both parts (1a, 1b) being mechanical joined but insulated from each other, and the coil is fitted directly on the tubular section (4) of the first part (1a) of the cartridge for triggering.
Patent AU-1761388-A (AU)
Title: Process for preparing sertraline intermediates
Inventor: QUALLICH GEORGE JOSEPH
IPC: C07C49/697
Filed: 1988-06-10
Abstract: A novel three-step process for preparing 4-(3,4-dichlorophenyl)-4-phenylbutanoic acid is disclosed, which involves (1) reducing 4-(3,4-dichlorophenyl)-4-ketobutanoic acid to 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid; (2) then converting the intermediate hydroxy acid formed in the first step to 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone, and (3) thereafter reacting the resulting gamma-butyrolactone compound with benzene in a Friedel-Crafts type reaction to form the desired final product. The latter compound is known to be useful as an intermediate leading to 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone and ultimately, to cis-(1S)(4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrah ydro-1-naphthaleneamine (sertraline), which is known to be a preferred anti-depressant agent in the field of medicinal chemistry. The aforementioned 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone and 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid are both novel compounds. There is also disclosed a novel process for converting 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone directly to 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone, as well as an alternate novel process for converting 4-(3,4-dichlorophenyl)-4-hydroxybutanoic acid directly to this same key intermediate.
Patent AU-1824795-A (AU)
Title: Patch containing isosorbide dinitrate and prepared by using adhesive mixture
Inventor: FUJII TAKAO
IPC: A61K31/34
Filed: 1995-02-28
Abstract: The present invention provides an ISDN-containing patch that causes minimal occurrence of skin rash and has excellent percutaneous absorption and adhesive strength. The present invention discloses an isosorbide dinitrate-containing patch comprising: an adhesive layer formed on a flexible support, wherein said layer comprises an adhesive composition containing adhesive and isosorbide dinitrate, the adhesive being composed of silicone-based adhesive (A) and polyvinyl acetate-based adhesive (B), their weight ratio being A:B = 85:15 to 15:85, and the weight ratio of isosorbide dinitrate (C) to the adhesives (A+B) being (A+B):C = 90:10 to 60:40.
Patent AU-1979699-A (AU)
Title: A stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole
Inventor: THACHARODI DILIPKUMAR
IPC: A61K9/48
Filed: 1999-01-26
Abstract: A pharmaceutical composition which is stable and suitable for oral administration to a patient comprises a mixture of a substituted pyridyl sulfinyl benzimidazole having gastric acid secretion inhibitory activity (such as omeprazole, lansoprazole, or pantoprazole), and a pharmaceutically acceptable carrier. The carrier comprises a polymer having vinyl pyrrolidone monomeric units, such as polyvinylpyrrolidone or a vinyl pyrrolidone-vinyl acetate copolymer. Surprisingly, it has been found that the vinylpyrrolidone polymer acts as a stabilizing excipient on the substituted pyridyl sulfinyl benzimidazole so that the composition need not include any alkaline components to prevent degradation of the active ingredient. In a preferred embodiment, the composition is in the form of a capsule, whereby the mixture of the substituted pyridyl sulfinyl benzimidazole and the vinyl pyrrolidone polymer in the form of a powder blend or granules, is contained within a capsule shell, which capsule shell is made from an enteric material or is coated with an enteric material. A process for preparing the stable pharmaceutical composition is also disclosed.
Patent AU-2329097-A (AU)
Title: Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
Inventor: HATTERSLEY GARY
IPC: A61P19/02
Filed: 1997-03-17
Abstract: Compositions of proteins with chondrocyte and cartilaginous tissue inducing activity, as well as method of using those compositions, are disclosed. The compositions comprise one or more proteins of the transforming growth factor- beta  (TGF- beta ) superfamily of proteins, particularly bone morphogenetic proteins (BMPs), in combination with parathyroid hormone related polypeptide (PTHrP) or an equivalent PTH-like polypeptide. The compositions and methods are useful in the treatment of osteoarthritis, cartilage defects and in related tissue repair.
Patent AU-2403997-A (AU)
Title: Automatic injection device
Inventor: GRECO ERMANNO
IPC: A61M5/20
Filed: 1997-04-14
Abstract: The present invention relates to improvements on automatic injection devices, in particular for self-administered drug therapies, providing for a high degree of internal stability of the syringe and, therefore, of the associated needle, thanks to a series of elastic wasp-waisted elements and a mobile tip made of a transparent material in the preferred embodiment, which besides enabling the regulation of the length of projection of the needle during the injection also allows the user to see the exact spot where the needle will enter the flesh.
Patent AU-2460488-A (AU)
Title: Iodine mirobicide composition
IPC: A01N25/06
Filed: 1988-11-02
Abstract: A substantially non-aqueous iodine microbicide composition comprising (a) a povidone-iodinein in an amount of from 0.0005% to 1.0% by weight based on the total amount of the compsition, and (b) a solvent comprising a lower alcohol having from 1 to 3 carbon atoms or a mixture of a lower alcohol having from 1 to 3 carbon atoms and a non-hydrated polyhydric alcohol, and an aerosol-type iodine microbicide composition containing the iodine microbicide composition.
Patent AU-2619700-A (AU)
Title: Pyridine compounds, use and preparation thereof
Inventor: STRUCK ROBERT F
IPC: C07D213/64
Filed: 2000-01-21
Abstract: New pyridine compounds are provided along with their method of preparation. The compounds are useful as intermediates in preparing new anticancer agents. A few of the pyridine compounds are also useful for treating cancer.
Patent AU-2640395-A (AU)
Title: System and method for filling and sealing containers in controlled environments
Inventor: SANFILIPPO JAMES J
IPC: B65B31/00
Filed: 1995-05-17
Abstract: An open-architecture system for filling and sealing containers (52) in controlled environments. The system provides easy access to containers being processed, and minimizes start-up times and waste. Containers are processed by gas distributors (which may comprise gassing rails (10)) provided in segments and individually movable between operating and service positions. Exhaust plenums (11) are described for improving function of the gas distributors when processing containers. Gas exchange systems including on-demand processors (5) and improved gassing elements are provided. An independent processor (5) is provided to receive, correct and environmentally process defective (e.g. underfilled or overfilled) containers (52).
Patent AU-2819992-A (AU)
Title: Hiv protease inhibitors useful for the treatment of aids
IPC: C07D417/12
Filed: 1992-11-06
Abstract: Cpds. of formula (I) and their salts are new. In the formula X = OH or NH2; Z = O, S or NH; R = H or 1-4C alkyl; R1,R2 = e.g. H, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl (opt. substd. by 1 or more from 1-4C alkyl, OH and aryl), -w-aryl, -w-benzyl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl etc, or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = 3-10 member satd. monocyclic or bicyclic ring contg. 1-8C and 1 or more additional heteroatom (opt. substd.), or R1+N+R2 = 3-10C member satd. monocyclic or bicyclic ring contg. 209C, fused to Ph (opt. substd. by 1 or more from halo, 1-3C alkoxy, OH, 1-4C alkyl, NHR, (where R1 is not joined to R2) and NH-heterocycle; R3 = (CH2)R4, 1-4C alkenyl-R4 or 1-4C alkynyl R4; R4 = eg. H, 1-4C alkyl, 5-10 cycloalkyl (opt. substd. by OH), 6-10C aryl (opt. substd. by 1 or more from halo, OH, NO2, NR2, 1-4C, 1-3C alkoxy (opt. substd. by 1 or more from OH and 1-3C alkoxy), CO2R, CONR2, CH2NR2, CH2NHCOR, CN, CF3, NHCOR etc, B = absent or -NH-CH(R8)-C(=Z)-; J1,J2 = -YR9, N(R9)2, NR10R11 or -Y(CR9R12)n-R12; W = O, S or NH; n = 0-3; R8 = CHMe2, CH(me)Et or Ph; Y = O or NH; R9 = eg. H, 1-6C alkyl (opt. substd. by 1 or more from NR2, OR, NHSO2 (1-4Calkyl), NHSO2 aryl, NHSO2 (dialkylaminoaryl) etc., R10+N+R11 = 5-7 member heterocycle opt. contg. 1 additional heteroatom O, S or NR); R12 = eg. H, aryl (opt. substd. by 1 or more from R14, -1-4C alkyl-NR2 and OCO(1-4Calkyl) etc.. R14 = halo, OR, CONR2, CH2NR2, SO2NR2, NR2, NHCOR, 1-4alkyl, Ph, CF3, N(R)SO2R, OP(O)(ORx)2 or CO2R.
Patent AU-2870189-A (AU)
Title: Blood extraction and reinfusion flow control system and method
Inventor: PRINCE PAUL RICHARD
IPC: A61M1/00
Filed: 1989-01-23
Abstract: A blood extraction and reinfusion flow control system includes a blood pump coupled to pump intravenous fluid to or from a subject, a pressure sensor coupled to sense extra veinous pressure at the subject, and a microprocessor based flow control subsystem. The flow control subsystem optimizes the flow rate by sensing pressure at at least two different fluid flow test points and extrapolating and translating the test point data to generate a flow control curve. The blood pump is then operated at a maximum speed that is limited by a desired maximum flow command and the flow control curve to maximize flow without vein collapse or damage during both blood extraction and reinfusion.
Patent AU-2873992-A (AU)
Title: Process for producing high-purity eicosapentaenoic acid or ester thereof
IPC: C11C1/08
Filed: 1992-10-28
Abstract: Eicosapentaenoic acid or an ester thereof, having a purity as high as at least 99 % and being useful for preventing or treating thrombosis, can be obtained in a recovery of 55 % or above by subjecting a mixture of fatty acids or esters thereof obtained from a natural fat or oil containing eicosapentaenoic acid or derivatives thereof to precise fractional distillation in a high vacuum by using a number of, particularly at least three, distillation columns to obtain a fraction mainly comprising C20 fatty acids or esters thereof, and subjecting this fraction to reversed phase column chromatography for fractional purification. <IMAGE>
Patent AU-2904799-A (AU)
Title: Therapeutic treatment for renal dysfunction
Inventor: WAYS DOUGLAS KIRK
IPC: A61K31/407
Filed: 1999-03-05
Abstract: A method for treating renal dysfunctions is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-ÄN,N'-1,1'-((2''-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-buta ne)-bis-(3,3'-indoly1)Ü-1(H)-pyrrole-2,5-dionehydrochloridesal t.
Patent AU-2914297-A (AU)
Title: Closable pouring cap
Inventor: LEGUE GERARDUS
IPC: B65D47/34
Filed: 1997-05-20
Abstract: PCT No. PCT/NL97/00277 Sec. 371 Date Dec. 14, 1998 Sec. 102(e) Date Dec. 14, 1998 PCT Filed May 20, 1997 PCT Pub. No. WO97/44247 PCT Pub. Date Nov. 27, 1997A closable pouring cap for a beverage container comprising a housing, a plunger movable in the housing and a pouring opening provided in the housing, while at its bottom side, which is placed on the container. The housing is provided with a fastener to attach the cap to the container and a duct is provided which extends from the bottom side of the housing to the pouring opening and which can be sealed by the plunger. The fastener comprises a seal made of elastic material through which the duct passes and the cap is provided with a pump connected to the duct for the withdrawal of gas present in the duct.
Patent AU-2944192-A (AU)
Title: Set of paving stones, process and device for producing the same
IPC: B28B7/00
Filed: 1992-11-20
Abstract: PCT No. PCT/EP92/02670 Sec. 371 Date May 19, 1994 Sec. 102(e) Date May 19, 1994 PCT Filed Nov. 20, 1992 PCT Pub. No. WO93/10310 PCT Pub. Date May 27, 1993.Paving stone set and process and device for the manufacture thereof. In the case of lawn-paving blocks formed from paving stones (10) spaced at a considerable distance apart, these are joined together, against relative displacements, by a holding grid (11) embedded in the paving stones (10) and comprising tension-resistant strands. The said holding grid allows the transfer of traction forces and hence the reciprocal safeguarding of the paving stones (10) within a paving stone set held together by the holding grid (11). The manufacture of the paving stone sets is effected in a concrete stone mold which is conventional in its principle. A flask (19) disposed on a molding plate (28) and a drawing sheet (29) is divided in the horizontal plane (33), creating a top part-flask (34) and a bottom part-flask (35). The holding grid (11) is clamped between the two part-flasks during pouring of the concrete. Following the completion of a paving stone set, the bottom part-flask (35) is withdrawn from the concrete stone mold. Demolding can now be carried out in the usual manner.
Patent AU-3004501-A (AU)
Title: Method and devices to provide a defined quality of service in a packet switched communication network
Inventor: FONDEN BENNY
IPC: H04Q11/04
Filed: 2000-11-29
Abstract: A method for the provision of a defined quality of service in a packet switched communication system with interconnected nodes (N) for the forwarding of data packets is described. The system comprises at least one edge node (EN) for the connection to user equipment (UE) or a further communication system (FS) and for processing data packets. The packets comprise a data field (10) specifying the handling of the packets and the nodes (N) perform a differentiated handling of packets according to said data field (10). The communication system comprises o is connectable to a data base (DB) which contains a record for a user specifying a quality of service. An edge node (EN) which processes a packet for said user is provided with quality parameters from the data base (DB). The edge node (EN) sets the data field (10) specifying the handling of the packet according to the record. Devices and programs to perform the method are also described. <IMAGE>   <IMAGE>
Patent AU-3005399-A (AU)
Title: Bone xenografts
Inventor: STONE KEVIN R
IPC: A61L27/36
Filed: 1999-03-15
Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic bone xenograft (X) for implantation into a defect (D) located in a bone portion (10) of a human. The invention further provides methods for preparing a bone xenograft (X) by removing at least a portion of bone from a non-human animal to provide a xenograft (X); washing the xenograft (X) in saline and alcohol; and subjecting the xenograft (X) to at least one of the treatments including exposure to ultraviolet radiation, immersion in alcohol, ozonic, and freeze/thaw cycling. In addition to or in lieu of the above treatments, the methods include a cellular disruption treatment, and digestion of the carbohydrate moieties of the xenograft (X) with a glycosidase followed by treatment for sialylation.
Patent AU-3010995-A (AU)
Title: Cyclohexadiene derivatives
IPC: C07D213/55
Filed: 1995-08-17
Abstract: Cyclohexadiene carboxylic acid derivs. of formula (Ia) or (Ib) and their salts are new: A = 6-10C aryl or pyridyl, opt. substd. by 1-3 of NO2, CN, halogen, 3-7C cycloalkyl, CF3, 1-6C alkylthio, 1-6C alkyl and 1-6C alkoxy; R1 = H or 1-8C alkyl; R2, R3 = , 1-6C alky lor 1-6C acyl; D = NO2 or 2-8C alkoxycarbonyl.
Patent AU-3024997-A (AU)
Title: Flush-marker light
Inventor: VANDEREN MICHEL
IPC: E01F9/06
Filed: 1997-05-23
Abstract: The invention relates to a lighting device for signalling on and identification and marking of airport traffic areas, e.g. take-off runways, landing runways, taxiways and the like. Said device has light sources (1) for direct emission of visible light. To reduce energy consumption and maintenance costs for said lighting devices, it is proposed that the light sources take the form of semiconductor components.
Patent AU-3091200-A (AU)
Title: An absorbent article having a material laminate that comprises a liquid permeable top sheet and a liquid permeable liquid transfer sheet
Inventor: HAGRUD ULRIKA
IPC: A61F13/511
Filed: 1999-12-15
Abstract: An absorbent article, such as a diaper, sanitary napkin, incontinence protector, wound dressing or the like, comprising an absorbent body (12) enclosed between a liquid-impermeable backing sheet (11) and a laminate (1) in the form of a liquid-permeable top sheet (2) and a liquid-permeable liquid transfer sheet (3), with the liquid transfer sheet (3) lying proximal to the absorbent body (12), in which article the liquid-permeable top sheet (2) and the liquid transfer sheet (3) are joined together and in which the absorbent body includes partially neutralised superabsorbent material.
Patent AU-3109799-A (AU)
Title: Methods and compositions for peptide synthesis
Inventor: KANG MYUNG-CHOL
IPC: C07K16/00
Filed: 1999-03-22
Abstract: The present invention relates, first, to methods for the synthesis of peptides, in particular T-20 (also referred to as "DP-178"; SEQ ID NO:1) and T-20-like peptides. Such methods utilize solid and liquid phase synthesis procedures to synthesize and combine groups of specific peptide fragments to yield the peptide of interest. The present invention further relates to individual peptide fragments which act as intermediates in the synthesis of the peptides of interest (e.g., T-20). The present invention still further relates to groups of such peptide intermediate fragments which can be utilized together to produce full length T-20 and T-20-like peptides.